Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.
New York University School of Medicine; and Hospital for Joint Diseases, Department of Medicine, 301 E. 17th St., New York 10003, New York, USA; E-mail: jose.scher@nyumc.org.
Jose U
JU
Scher
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000209:etiology*; D001424:Bacterial Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
D000900:Anti-Bacterial Agents